Scaleable processes for the synthesis of (−)-β-D-2,6-diaminopurine dioxolane (Amdoxovir, DAPD) and (−)-β-D-2-aminopurine dioxolane (APD)

類似資料

• Synthesis and anti-HIV activity of (-)-β-D-(2R,4R) 1,3-dioxolane 2,6-diamino purine (DAPD) (Amdoxovir) and (-)-β-D-(2R,4R) 1,3-dioxolane guanosine (DXG) prodrugs
  著者:: Narayanasamy, Janarthanan, 等
  出版事項: (2007)
• Pharmacokinetics of (-)-beta-D-2-aminopurine dioxolane and (-)-beta-D-2-amino-6-chloropurine dioxolane and their antiviral metabolite (-)-beta-D-dioxolane guanine in rhesus monkeys.
  著者:: Chen, H, 等
  出版事項: (1996)
• Mechanism of Action of 1-β-d-2,6-Diaminopurine Dioxolane, a Prodrug of the Human Immunodeficiency Virus Type 1 Inhibitor 1-β-d-Dioxolane Guanosine
  著者:: Furman, Phillip A., 等
  出版事項: (2001)
• β-d-2′-C-Methyl-2,6-diaminopurine Ribonucleoside Phosphoramidates are Potent and Selective Inhibitors of Hepatitis C Virus (HCV) and Are Bioconverted Intracellularly to Bioactive 2,6-Diaminopurine and Guanosine 5′-Triphosphate Forms
  著者:: Zhou, Longhu, 等
  出版事項: (2015)
• Intracellular metabolism and potential cardiotoxicity of a β-D-2’-C-methyl-2,6-diaminopurine ribonucleoside phosphoramidate that inhibits hepatitis C virus replication
  著者:: Tao, Sijia, 等
  出版事項: (2019)